Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 794 GBX -0.83% Market Closed
Market Cap: 4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Hikma Pharmaceuticals PLC
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikma Pharmaceuticals PLC
Note Receivable Peer Comparison

Comparables:
GSK
AZN
VRNA
INDV
DPH

Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Hikma Pharmaceuticals PLC
LSE:HIK
Note Receivable
$14m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AstraZeneca PLC
LSE:AZN
Note Receivable
$806m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
-5%
Verona Pharma PLC
NASDAQ:VRNA
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Note Receivable
$12m
CAGR 3-Years
-47%
CAGR 5-Years
-30%
CAGR 10-Years
9%
Dechra Pharmaceuticals PLC
LSE:DPH
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hikma Pharmaceuticals PLC's Note Receivable?
Note Receivable
14m USD

Based on the financial report for Jun 30, 2024, Hikma Pharmaceuticals PLC's Note Receivable amounts to 14m USD.

What is Hikma Pharmaceuticals PLC's Note Receivable growth rate?
Note Receivable CAGR 1Y
-33%

Over the last year, the Note Receivable growth was -33%.

Back to Top